Ethan Walker writes for the Pharma and Biotech desk at Trend & Ticker. The desk follows pharmaceutical and biotechnology companies, drug pipelines and the regulatory events that move their shares. Corrections are published openly on the affected article.
-
2 المنشورات
-
1 الصور
-
0 الفيديوهات
-
Pharma and Biotech لدى California
-
يعيش في California City, CA, United States
-
من California City, CA, United States
-
درس California لدى High Schoolفئة من 10
-
Male
-
أعزب
-
02/01/1998
-
متابَع بواسطة 0 أشخاص
التحديثات الأخيرة
-
Alvotech (ALVO) files first known Eylea 8 mg biosimilar application in EuropeAlvotech and Advanz Pharma sent AVT29 to the European Medicines Agency on 14 October 2026 as a line extension to Mynzepli, the Eylea 2 mg biosimilar. Alvotech (ALVO) and its partner Advanz Pharma submitted AVT29 to the European Medicines Agency on 14 October 2026, according to a company release issued the same day. AVT29 is a proposed biosimilar to Eylea 8 mg, the higher-dose form of...0 التعليقات 0 المشاركات 6 مشاهدة 0 معاينةالرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
0 التعليقات 0 المشاركات 2 مشاهدة 0 معاينة
المزيد من المنشورات